Molecular Genetic Analysis of RB1 gene among Sudanese children with Retinoblastoma
Nada O. Ibrahim, Mahgoub Saleem, Entesar Eltayeb, Salwa Osman Mekki, Elteleb G. Elnaim, Abeer Babiker IdrisiD, Sanaa Bashir, Mohammed A. Salim, Mohamed Ahmed Salih HassaniD
Abstract
BACKGROUNDRetinoblastoma (RB), the commonest early childhood intraocular tumor, is most often related to mutations in the RB1 gene with an incidence of 3% of all pediatric tumors. It has good prognosis if diagnosed early but it is life-threatening when diagnosed late.\n\nOBJECTIVETo study the Molecular Genetic Analysis of Retinoblastoma (RB) in Sudanese families.\n\nMETHODSThirty one (n=31) clinically and histopathologically diagnosed cases of RB attending Makkah Eye Complex (MEC) Orbit clinic (Khartoum, Sudan) were included in this Molecular Genetic RB Analysis. Fresh blood samples extracted from seven RB patients and 15 close families for DNA extraction and PCR were sent for Genetic Sequencing and In silico approach for \"Exon 18 mutations\" which is one of the highly mutated exons worldwide.\n\nRESULTSThe majority of patients (41.9%) were below five years old. Females were 58.1%, males were 41.9%. Leukocoria was the commonest sign at presentation (41.9%). RB Unilaterality were in (77.4%) while Bilaterality in 19.4%. Both eyes were equally affected 50% each. The age at diagnosis time ranged from 0.02 to five years. Consanguinity of parents was very high (85.7%), the 1st degree cousins were less (28.6%) while the 2nd degree was high (57.1%). The patients ethnic background and geographical area were from seven different tribes; all belong to the Western Sudan. The molecular genetic study showed that exon 18 was free of mutation among the seven patients + their three relatives. The Functional Analysis and (SNPs) prediction study of exon 18 from NCBI data base showed that the various computational approaches used (SIFT, PolyPhen-2, I-mutant and Project hope) identified 16 reported mutations worldwide, three of which (rs137853292, rs375645171 and rs772068738) are major nsSNPs (non-synonymous) which might contribute to native RB1 protein malfunction and ultimately causing carcinoma.\n\nCONCLUSIONRB mainly affected children under five years and both sexes are equally affected. Unilaterality was predominant. Consanguinity plays a role in inheritance and the majority of patients were from Western Sudan. The most commonly detected deleterious mutations worldwide in exon 18 were not found in the Sudanese studies samples. Further screening for the highly reported mutations in exons 8, 10 and 14 or Next Generation Sequencing (NGS) are recommended. In silico tools are useful in studying the functional analysis of SNPs.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 3
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- RB1 sequence variants in retinoblastoma. Analysis of RB1 variants in a database for correlation with pRB protein domains and clinical presentation
Nicohol Tovar Martelo, Irene Szijan·BiomedicinesPeer-reviewed·Nov 2, 2025
- Genome-wide investigation of rare germline copy-number variants in retinoblastoma
Lesley M. Chapman, Jung Kim, … Zois Boukouvalas·medRxiv·Nov 19, 2024
- Prevalence and Penetrance of Heritable Retinoblastoma in Two Adult Population Cohorts: Implications for genomic newborn screening
Isabella-Anna Lazaridi, Timothy S. Hall, … Leigh M. Jackson·European Journal of Human GeneticsPeer-reviewed·Sep 18, 2026
- Developmental-stage-specific proliferation and retinoblastoma genesis in RB-deficient human but not mouse cone precursors
H. P. Singh, S. Wang, … D. Cobrinik·bioRxiv·Jun 26, 2018
- RB1 loss triggers dependence on ESRRG in retinoblastoma
M. G. Field, J. N. Kuznetsoff, … J. W. Harbour·bioRxiv·Dec 15, 2021
- Modeling the age distribution of retinoblastomas
A. N. Tetearing·bioRxiv·Nov 24, 2021